Immunomodulatory effects of Bacillus subtilis (natto) B4 spores on murine macrophages

Microbiology and Immunology

Volumn 56, Issue 12, 2012, Pages 817-824

  Xu, Xin ^a   Huang, Qin ^a   Mao, Yulong ^a   Cui, Zhiwen ^a   Li, Yali ^a   Huang, Yi ^a   Rajput, Imran Rashid ^a   Yu, Dongyou ^a   Li, Weifen ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bacillus subtilis (natto); Immunomodulation; Macrophage; Spore

Indexed keywords

ACID PHOSPHATASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MACROPHAGE INFLAMMATORY PROTEIN 2; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACILLUS SUBTILIS; BACTERIAL SPORE; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME ACTIVITY; IMMUNOMODULATION; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; SUPERNATANT; UPREGULATION;

ACID PHOSPHATASE; ANIMALS; BACILLUS SUBTILIS; CELL LINE; CELL SURVIVAL; CYTOKINES; L-LACTATE DEHYDROGENASE; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SPORES, BACTERIAL;

BACILLUS SUBTILIS; MURINAE;

EID: 84870315331     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00508.x     Document Type: Article

References (71)

1. Ashiuchi M., Tani K., Soda K., Misono H. (1998) Properties of glutamate racemase from Bacillus subtilis IFO 3336 producing poly-gamma-glutamate. J Biochem 123: 1156-63.
2. Hosoi T., Kiuchi K. (2004) Production and probiotic effects of natto. In: Ricca, E., Henriques, A.O. & Cutting, S.M. eds. Horizon Bioscience. UK: Wymondham.
3. Hosoi T., Ametani A., Kiuchi K., Kaminogawa S. (1999) Changes in fecal microflora induced by intubation of mice with Bacillus subtilis (natto) spores are dependent upon dietary components. Can J Microbiol 45: 59-66.
4. Hosoi T., Ametani A., Kiuchi K., Kaminogawa S. (2000) Improved growth and viability of lactobacilli in the presence of Bacillus subtilis (natto), catalase, or subtilisin. Can J Microbiol 46: 892-7.
5. Inooka S., Uehara S., Kimura M. (1986) The effect of Bacillus natto on the T and B lymphocytes from spleens of feeding chickens. Poult Sci 65: 1217-9.
6. Samanya M., Yamauchi K.E. (2002) Histological alterations of intestinal villi in chickens fed dried Bacillus subtilis var. natto. Comp Biochem Physiol A Mol Integr Physiol 133: 95-104.
7. Hong H.A., Duc L.H., Cutting S.M. (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29: 813-35.
8. Laskin D.L. (2009) Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol 22: 1376-85.
9. Adams D.O., Hamilton T.A. (1984) The cell biology of macrophage activation. Annu Rev Immunol 2: 283-318.
10. Xia Y., Zweier J.L. (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A 94: 6954-8.
11. Giroux M., Descoteaux A. (2000) Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha. J Immunol 165: 3985-91.
12. Bosca L., Zeini M., Traves P.G., Hortelano S. (2005) Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 208: 249-58.
13. Cavaillon J.M. (1994) Cytokines and macrophages. Biomed Pharmacother 48: 445-53.
14. Wu T.T., Chen T.L., Chen R.M. (2009) Lipopolysaccharide triggers macrophage activation of inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a toll-like receptor 4-dependent pathway: validated by RNA interference. Toxicol Lett 191: 195-202.
15. Ganz T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-20.
16. Kim D.W., Cho S.B., Lee H.J., Chung W.T., Kim K.H., Hwangbo J., Nam I.S., Cho Y., Yang M.P., Chung I.B. (2007) Comparison of cytokine and nitric oxide induction in murine macrophages between whole cell and enzymatically digested Bifidobacterium sp obtained from monogastric animals. J Microbiol 45: 305-10.
17. Kim D.W., Cho S.B., Yon C.H., Jeong H.Y., Chung W.T., Choi C.W., Lee H.J., Nam I.S., Suh G.H., Lee S.S., Lee B.S. (2007) Induction of cytokines and nitric oxide in murine macrophages stimulated with enzymatically digested lactobacillus strains. J Microbiol 45: 373-8.
18. Kim N., Ji G.E. (2006) Modulatory activity of Bifidobacterium sp BGN4 cell fractions on immune cells. J Microbiol Biotechnol 16: 584-9.
19. Park S.Y., Ji G.E., Ko Y.T., Jung H.K., Ustunol Z., Pestka J.J. (1999) Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int J Food Microbiol 46: 231-41.
20. Zhu J., Zhao L.A., Guo H.Y., Jiang L., Ren F.Z. (2011) Immunomodulatory effects of novel bifidobacterium and lactobacillus strains on murine macrophage cells. Afr J Microbiol Res 5: 8-15.
21. Duc L., Hong H.A., Fairweather N., Ricca E., Cutting S.M. (2003) Bacterial spores as vaccine vehicles. Infect Immun 71: 2810-8.
22. Duc L.H., Hong H.A., Cutting S.M. (2003) Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen delivery. Vaccine 21: 4215-24.
23. Sarir H., Mortaz E., Janse W.T., Givi M.E., Nijkamp F.P., Folkerts G. (2010) IL-8 production by macrophages is synergistically enhanced when cigarette smoke is combined with TNF-alpha. Biochem Pharmacol 79: 698-705.
24. Weyermann J., Lochmann D., Zimmer A. (2005) A practical note on the use of cytotoxicity assays. Int J Pharm 288: 369-76.
25. Chen X., Lu J., Zhang Y., He J., Guo X., Tian G., Jin L. (2008) Studies of macrophage immuno-modulating activity of polysaccharides isolated from Paecilomyces tenuipes. Int J Biol Macromol 43: 252-6.
26. Huang Y., Xu Y., Yamagishi H., Hagiwara A. (2001) Tumor cytotoxicity of peritoneal macrophages induced by OK-432. Anticancer Drugs 12: 781-5.
27. Saarela M., Mogensen G., Fonden R., Matto J., Mattila-Sandholm T. (2000) Probiotic bacteria: safety, functional and technological properties. J Biotechnol 84: 197-215.
28. Hong H.A., Huang J.M., Khaneja R., Hiep L.V., Urdaci M.C., Cutting S.M. (2008) The safety of Bacillus subtilis and Bacillus indicus as food probiotics. J Appl Microbiol 105: 510-20.
29. Sorokulova I.B., Pinchuk I.V., Denayrolles M., Osipova I.G., Huang J.M., Cutting S.M., Urdaci M.C. (2008) The safety of two Bacillus probiotic strains for human use. Dig Dis Sci 53: 954-63.
30. Tompkins T.A., Hagen K.E., Wallace T.D., Fillion-Forte V. (2008) Safety evaluation of two bacterial strains used in Asian probiotic products. Can J Microbiol 54: 391-400.
31. Patel P., Markx G.H. (2008) Dielectric measurement of cell death. Enzyme Microb Technol 43: 463-70.
32. Korzeniewski C., Callewaert D.M. (1983) An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64: 313-20.
33. Drent M., Cobben N.a.M., Henderson R.F., Wouters E.F.M., Vandieijenvisser M. (1996) Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 9: 1736-42.
34. Sugiura H., Sugiura H., Nishida H., Inaba K., Mirbod S.M., Iwata H. (2000) Immunomodulation by 8-week voluntary exercise in mice. Acta Physiol Scand 168: 413-20.
35. Ryan J.L., Glode L.M., Rosenstreich D.L. (1979) Lack of responsiveness of C3H/HeJ macrophages to lipopolysaccharide: the cellular basis of LPS-stimulated metabolism. J Immunol 122: 932-5.
36. Sugiura H., Ueya E., Ueya S., Mirbod S.M. (2000) Enhanced macrophage functions and cytokine production of lymphocytes after ingestion of bon narine in female BALB/c mice. Life Sci 68: 505-15.
37. Hibbs J.B. (1991) Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumor and antimicrobial activity. Res Immunol 142: 565-9.
38. Hickey M.J. (2001) Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin Sci 100: 1-12.
39. Ignarro L.J. (1990) Nitric oxide. a novel signal transduction mechanism for transcellular communication. Hypertension 16: 477-83.
40. Murad F. (1994) The nitric oxide cyclic-Gmp signal-transduction system for intracellular and intercellular communication. Recent Progress in Hormone Research, 49: 239-48.
41. Forman H.J., Torres M. (2001) Redox signaling in macrophages. Mol Aspects Med 22: 189-216.
42. Kim S., Ponka P. (2002) Nitric oxide-mediated modulation of iron regulatory proteins: implication for cellular iron homeostasis. Blood Cells Mol Dis 29: 400-10.
43. Gomez-Flores R., Weber R.J. (1998) Immunomodulation of macrophage functions by opioids. Adv Exp Med Biol 437: 13-9.
44. Macmicking J.D., North R.J., Lacourse R., Mudgett J.S., Shah S.K., Nathan C.F. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 94: 5243-8.
45. Schoedon G., Schneemann M., Walter R., Blau N., Hofer S., Schaffner A. (1995) Nitric oxide and infection: another view. Clin Infect Dis 21: S152-S57.
46. Klimp A.H., De Vries E.G.E., Scherphof G.L., Daemen T. (2002) A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 44: 143-61.
47. Albina J.E., Reichner J.S. (1998) Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev 17: 39-53.
48. Armstrong R. (2001) The physiological role and pharmacological potential of nitric oxide in neutrophil activation. Int Immunopharmacol 1: 1501-12.
49. Cifone M.G., Ulisse S., Santoni, A. (2001) Natural killer cells and nitric oxide. Int Immunopharmacol 1: 1513-24.
50. Forsythe P., Gilchrist M., Kulka M., Befus A.D. (2001) Mast cells and nitric oxide: control of production, mechanisms of response. Int Immunopharmacol 1: 1525-41.
51. Arai K.I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59: 783-6.
52. Stoycheva M., Murdjeva M. (2005) Dynamics of serum pro-inflammatory cytokines in patients with salmonella infection. Trakia J Sci 3: 56-60.
53. Balkwill F. (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9: 361-71.
54. Bradley J.R. (2008) TNF-mediated inflammatory disease. J Pathol 214: 149-60.
55. Farrar M.A., Schreiber R.D. (1993) The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 11: 571-611.
56. Dinarello C.A. (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-50.
57. Jones S.A. (2005) Directing transition from innate to acquired immunity defining a role for IL-6. J Immunol 175: 3463-8.
58. Hebert C.A., Luscinskas F.W., Kiely J.M., Luis E.A., Darbonne W.C., Bennett G.L., Liu C.C., Obin M.S., Gimbrone M.A., Baker J.B. (1990) Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol 145: 3033-40.
59. Waugh D.J.J., Wilson C. (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14: 6735-41.
60. Shahzad A., Knapp M., Lang I., Kohler, G. (2010) Interleukin 8 (IL-8) - a universal biomarker Int Arch Med 3: 11.
61. Jerva L.F., Sullivan G., Lolis E. (1997) Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes. Protein Sci 6: 1643-52.
62. Trinchieri G. (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-46.
63. De Waal Malefyt R.D., Abrams J., Bennett B., Figdor C.G., De Vries J.E. (1991) Interleukin-10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-20.
64. Mosser D.M., Zhang X. (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226: 205-18.
65. Opitz B., Schroder N.W., Spreitzer I., Michelsen K.S., Kirschning C.J. Hallatschek W., Zahringer U., Hartung T., Gobel U.B., Schumann R.R. (2001) Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J Biol Chem 276: 22, 041-7.
66. Baeuerle P.A., Baltimore D. (1996) NF-kappa B: ten years after. Cell 87: 13-20.
67. Leib S.L., Täuber M.G. (2004) Pathogenesis and pathophysiology of bacterial infections. In: Scheld W.M., Whitley R.J., Marra, C.M. eds. Infections of the central nervous system, 3 edn. New York: Lippincott Williams & Wilkins.
68. Shimauchi H., Ogawa T., Okuda K., Kusumoto Y., Okada H. (1999) Autoregulatory effect of interleukin-10 on proinflammatory cytokine production by Porphyromonas gingivalis lipopolysaccharide-tolerant human monocytes. Infect Immun 67: 2153-9.
69. Platzer C., Meisel C., Vogt K., Platzer M., Volk H.D. (1995) Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 7: 517-23.
70. Morita H., He F., Fuse T., Ouwehand A.C., Hashimoto H., Hosoda M., Mizumachi K., Kurisaki J. (2002) Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci, Biotechnol, Biochem 66: 1963-6.
71. Setlow P. (2006) Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J Appl Microbiol 101: 514-25.